⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8303875 | 1.00 | — | — | |
| SCHEMBL10638426 | 0.82 | MAOA (0.34) | — | |
| SCHEMBL12240486 | 0.73 | — | — | |
| SCHEMBL12240470 | 0.73 | — | — | |
| SCHEMBL486427 | 0.73 | — | — | |
| SCHEMBL2304187 | 0.71 | — | — | |
| SCHEMBL28758779 | 0.71 | — | — | |
| SCHEMBL22606207 | 0.71 | — | — | |
| SCHEMBL27586076 | 0.71 | — | — | |
| SCHEMBL14791328 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-8157459-A | — | — | None | — | — | JP | disclosed |
| US-20190105412-A1 | NOVEL MOLECULAR ASSEMBLY, MOLECULAR PROBE FOR MOLECULAR IMAGING AND MOLECULAR PROBE FOR DRUG DELIVERY SYSTEM USING THE SAME, AND MOLECULAR IMAGING SYSTEM AND DRUG DELIVERY SYSTEM | SHIMADZU CORPORATION (JP) | 2019-04-11 | — | — | US | disclosed |
| CN-105820161-A | Synthetic method of rivaroxaban intermediate 5-hydroxy methyl oxazolidinone derivative | 常州方楠医药技术有限公司 | 2016-08-03 | — | — | CN | disclosed |
| CN-105820161-A | Synthetic method of rivaroxaban intermediate 5-hydroxy methyl oxazolidinone derivative | 常州方楠医药技术有限公司 | 2016-08-03 | — | — | CN | disclosed |
| JP-H08157459-A | PRODUCTION OF OPTICALLY ACTIVE 5-HYDROXYMETHYL-OXAZOLIDINONE DERIVATIVE | NIPPON KAYAKU CO LTD | 1996-06-18 | — | — | JP | disclosed |